Cutaneous malignant melanoma in Scotland.

por MacKie, R. M., Hunter, J. A.
Publicado 1982

Reply to letter by Drs Gillis and Hole

por MacKie, R. M., Hunter, J. A. A.
Publicado 1982

Impact of proximity of healthier versus less healthy foods on intake: A lab-based experiment

por Hunter, J.A., Hollands, G.J., Pilling, M., Marteau, T.M.
Publicado 2019

Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenita...

por Arends, M. J., Benton, E. C., McLaren, K. M., Stark, L. A., Hunter, J. A., Bird, C. C.
Publicado 1997

Adjuvant interferon alpha 2b in high risk melanoma – the Scottish study

por Cameron, D A, Cornbleet, M C, Mackie, R M, Hunter, J A A, Gore, M, Hancock, B, Smyth, J F
Publicado 2001

Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion.

por Stark, L. A., Arends, M. J., McLaren, K. M., Benton, E. C., Shahidullah, H., Hunter, J. A., Bird, C. C.
Publicado 1994

Accumulation of p53 is associated with tumour progression in cutaneous lesions of renal allograft recipients.

por Stark, L. A., Arends, M. J., McLaren, K. M., Benton, E. C., Shahidullah, H., Hunter, J. A., Bird, C. C.
Publicado 1994

The relation between mortality from malignant melanoma and early detection in the Cancer Research Campaign Mole Watcher Study

por Melia, J, Moss, S, Coleman, D, Frost, T, Graham-Brown, R, Hunter, J A A, Marsden, R A, Vivier, A du, Warin, A P, White, J, Whitehead, S M, Wroughton, M A
Publicado 2001